Prader-willi Syndrome

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2008-12-16
Clinical Trial Update: Exploring Stress and Coping Behaviors of the Major Carer Whose Children With Prader-Willi Syndrome
A clinical trial update describing a study on stress and coping behaviors of the primary caregiver of children with Prader-Willi syndrome; n…
CLINICAL_TRIALS research · 2008-12-02
Clinical Trial Update: Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome
A completed Samsung Medical Center–sponsored clinical trial reports increased expression of adiponectin receptor 2 in mononuclear cells from…
CLINICAL_TRIALS trial_result · 2007-10-31
Clinical Trial Update: Prader-Willi Syndrome and Appetite [Phase 3]
Phase 3 trial for Prader-Willi syndrome focusing on hyperphagia was terminated.
FDA approval · 2007-09-20
FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Norditropin (somatropin) from Novo Nordisk, indicating an approved update to the existing BLA.
CLINICAL_TRIALS trial_result · 2007-05-17
Clinical Trial Update: Correlation of Hyperghrelinemia With Carotid Artery Intima-Media Thickness in Children With Prader-Willi Syndrome
A completed clinical trial examining whether elevated ghrelin levels correlate with carotid intima-media thickness in children with Prader-W…
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
FDA approval · 2006-11-01
FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMATROPE (somatropin) submitted by Eli Lilly and Company.
FDA approval · 2006-10-26
FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMATROPE (somatropin) submitted by Eli Lilly and Company.